Current Data on COVID-19 mRNA-Vaccine Safety during Pregnancy Might Be Subject to Selection Bias. Reply to Stroobandt, S.; Stroobandt, R. Data of the COVID-19 mRNA-Vaccine V-Safe Surveillance System and Pregnancy Registry Reveals Poor Embryonic and Second Trimester Fetal Survival Rate. Comment on “Stuckelberger et al. SARS-CoV-2 Vaccine Willingness among Pregnant and Breastfeeding Women during the First Pandemic Wave: A Cross-Sectional Study in Switzerland. <i>Viruses</i> 2021, <i>13</i>, 1199”
Sarah Stuckelberger,
Guillaume Favre,
Michael Ceulemans,
Eva Gerbier,
Valentine Lambelet,
Milos Stojanov,
Ursula Winterfeld,
David Baud,
Alice Panchaud,
Léo Pomar
Affiliations
Sarah Stuckelberger
Department Woman-Mother-Child, Lausanne University Hospital, University of Lausanne, 1011 Lausanne, Switzerland
Guillaume Favre
Department Woman-Mother-Child, Lausanne University Hospital, University of Lausanne, 1011 Lausanne, Switzerland
Michael Ceulemans
Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, 3000 Leuven, Belgium
Eva Gerbier
Department Woman-Mother-Child, Lausanne University Hospital, University of Lausanne, 1011 Lausanne, Switzerland
Valentine Lambelet
Department Woman-Mother-Child, Lausanne University Hospital, University of Lausanne, 1011 Lausanne, Switzerland
Milos Stojanov
Department Woman-Mother-Child, Lausanne University Hospital, University of Lausanne, 1011 Lausanne, Switzerland
Ursula Winterfeld
Swiss Teratogen Information Service, Service de Pharmacologie Clinique, Lausanne University Hospital, University of Lausanne, 1011 Lausanne, Switzerland
David Baud
Department Woman-Mother-Child, Lausanne University Hospital, University of Lausanne, 1011 Lausanne, Switzerland
Alice Panchaud
Institute of Primary Health Care (BIHAM), University of Bern, 3012 Bern, Switzerland
Léo Pomar
Department Woman-Mother-Child, Lausanne University Hospital, University of Lausanne, 1011 Lausanne, Switzerland
